- Home
- CMRE vs EWTX Comparison
CMRE vs EWTX Comparison
Compare CMRE & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMRE
- EWTX
- Stock Information
- Founded
- CMRE 1974
- EWTX 2017
- Country
- CMRE Monaco
- EWTX United States
- Employees
- CMRE N/A
- EWTX N/A
- Industry
- CMRE Marine Transportation
- EWTX Biotechnology: Pharmaceutical Preparations
- Sector
- CMRE Consumer Discretionary
- EWTX Health Care
- Exchange
- CMRE Nasdaq
- EWTX Nasdaq
- Market Cap
- CMRE 1.5B
- EWTX 1.6B
- IPO Year
- CMRE 2010
- EWTX 2021
- Fundamental
- Price
- CMRE $14.64
- EWTX $23.08
- Analyst Decision
- CMRE Hold
- EWTX Buy
- Analyst Count
- CMRE 1
- EWTX 10
- Target Price
- CMRE $12.00
- EWTX $37.30
- AVG Volume (30 Days)
- CMRE 525.0K
- EWTX 1.1M
- Earning Date
- CMRE 11-04-2025
- EWTX 11-06-2025
- Dividend Yield
- CMRE 3.15%
- EWTX N/A
- EPS Growth
- CMRE N/A
- EWTX N/A
- EPS
- CMRE 2.51
- EWTX N/A
- Revenue
- CMRE $2,085,335,000.00
- EWTX N/A
- Revenue This Year
- CMRE N/A
- EWTX N/A
- Revenue Next Year
- CMRE N/A
- EWTX N/A
- P/E Ratio
- CMRE $5.88
- EWTX N/A
- Revenue Growth
- CMRE 41.07
- EWTX N/A
- 52 Week Low
- CMRE $6.02
- EWTX $10.60
- 52 Week High
- CMRE $14.79
- EWTX $35.50
- Technical
- Relative Strength Index (RSI)
- CMRE 80.89
- EWTX 75.26
- Support Level
- CMRE $11.92
- EWTX $19.87
- Resistance Level
- CMRE $14.79
- EWTX $18.26
- Average True Range (ATR)
- CMRE 0.43
- EWTX 1.53
- MACD
- CMRE 0.25
- EWTX 0.51
- Stochastic Oscillator
- CMRE 96.54
- EWTX 86.87
About CMRE Costamare Inc. $0.0001 par value
Costamare Inc is an international owner and operator of containerships and dry bulk vessels. The company charter its containerships to the liner companies, providing transportation of containerized cargoes. It charter its dry bulk vessels to a wide variety of customers, providing transportation for dry bulk cargoes. The company's fleet of vessels includes Cosco Guangzhou, Cosco Ningbo, Cosco Yantian, Vantage, Valor, Valiant, Maersk Kobe, and among others. Costamare provides services to ocean carriers that demand a high standard of safety and reliability. It generates a majority of its revenue from the United States of America.
About EWTX Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.